Medically, you might be interested in...
A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’, compiled and written by Clare GP Dr Ray O’Connor
Stay updated with breaking news from Randomized Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’, compiled and written by Clare GP Dr Ray O’Connor
ORAL-B AND STRAUMANN PARTNER ON A LANDMARK ALLIANCE FOR SCIENTIFIC EDUCATION TO IMPROVE THE PERIODONTAL AND PERI-IMPLANT HEALTH OF PATIENTS WORLDWIDE First official announcement and launch on 17th
First official announcement and launch on 17th June 2022 during EuroPerio10 in Copenhagen Oral-B and Straumann, two of the world's leading oral care companies, are proud to announce a new global
Why have SGLT2-inhibitor clinical benefits in HFrEF trials been evident so soon after the drugs are started? Recent studies shed light on one potential mechanism among what are probably many.
A broad overview of the role vitamin D in the immune system, especially in the pathogenesis & treatment of IBD, & its possible role in predicting relapse.